CHORIOCARCINOMA

This adverse event was reported 79 times

These drugs are most commonly taken by patients reporting CHORIOCARCINOMA:

# Drug Count
0 ETOPOSIDE 32
1 METHOTREXATE SODIUM 30
2 METHOTREXATE 27
3 CISPLATIN 18
4 CYCLOPHOSPHAMIDE 18
5 CYCLOPHOSPHAMIDE FOR INJECTION 18
6 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 18
7 BLEOMYCIN SULFATE 11
8 DACTINOMYCIN 8
9 BLEOMYCIN 7
See all common drugs associated with CHORIOCARCINOMA

CHORIOCARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FLOXURIDINE 1 0.0058
1 DACTINOMYCIN 8 0.0036
2 PLATINUM 1 0.0019
3 DINOPROSTONE 1 0.0012
4 BLEOMYCIN SULFATE 11 0.0011
5 VINBLASTINE SULFATE 2 0.0010
6 1168 BURN SPRAY 2 0.0007
7 PROCARBAZINE HYDROCHLORIDE 3 0.0006
8 ALLANTOIN 2 0.0006
9 ERTAPENEM SODIUM 4 0.0005
See all drugs enriched for association with CHORIOCARCINOMA

CHORIOCARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 8 0.0036
1 Topoisomerase Inhibitor [EPC] 32 0.0004
2 Oxytocic [EPC] 1 0.0003
3 Alkylating Drug [EPC] 24 0.0001
4 Platinum-based Drug [EPC] 22 0.0001
5 Folate Analog Metabolic Inhibitor [EPC] 27 0.0001
6 Nitroimidazole Antimicrobial [EPC] 4 0.0001
7 Carbonic Anhydrase Inhibitor [EPC] 1 0.0000
8 Microtubule Inhibitor [EPC] 6 0.0000
9 Leukocyte Growth Factor [EPC] 5 0.0000
See all drug classes enriched for association with CHORIOCARCINOMA